Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
10,650
+150 (1.43%)
Aug 10, 2026, 5:27 PM IDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue from Sale of Goods
14.57B14.61B14.05B
Licensing Arrangements Revenue
672.00M678.00M173.00M
Distribution Revenue
1.62B1.55B1.58B
Other Segment Revenue
457.00M423.00M745.00M
Revenue (Other)
1.00M1.00M-
Revenue (Total)
17.32B17.26B16.54B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Revenue
8.36B9.19B8.03B
Europe Revenue
5.15B5.04B5.10B
International Markets Revenue
2.16B2.16B2.46B
Other Activities Revenue
1.64B870.00M944.00M
Revenue (Total)
17.32B17.26B16.54B

Adjusted EBIT by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States Segment Profit
2.55B3.36B2.30B
Europe Segment Profit
1.38B1.30B1.58B
International Markets Segment Profit
329.00M336.00M440.00M
Other Activities Segment Profit
-98.00M-90.00M18.00M
Operating Income (Total)
1.60B2.16B-303.00M